Real estate, home construction down after Moody39;s warning
Network International up after agreeing to PE deal
Amigo grants shareholder rights to help raise funds
Croda set for biggest drop since 2000
FTSE 100 slides 0.04, FTSE 250 off 0.2

June 9 Reuters UK39;s FTSE 100 traded slightly lower on Friday as a steep fall in shares of chemicals firm Croda following a downbeat profit forecast outweighed a boost from AstraZeneca.

The FTSE 100 benchmark index slid 0.04, while the FTSE 250 midcap index slipped 0.2.

The chemicals sector lost 9.2, dragged down by a 15.3 fall in component Croda International, which disappointed investors by forecasting a pretax annual profit below expectations.

Croda has been suffering from customer destocking due to an oversupply of goods, said Joshua Warner, market analyst at City Index.

It has partially countered lower volumes in consumer care with higher prices, while life sciences has seen destocking happen quicker than anticipated.

AstraZeneca climbed 0.8 after the Food and Drug Administration advisers backed the use of the drugmaker and partner Sanofi39;s experimental antibody to prevent respiratory infections in infants.

The healthcare firm also said it had signed an agreement with Quell Therapeutics potentially worth more than 2 billion to develop cell therapies curing autoimmune diseases.

The broader healthcare sector added 0.6.

Shares of Network International jumped 5.8 after Brookfield Asset Management said it had reached…